Tekmira Pharma (Nasdaq: TKMR) stock surged more than 25% to $26.50 Wednesday after the CDC confirmed Tuesday the first Ebola diagnosis in the United States - and the first outside of Africa.
But just how close is Tekmira to getting approval for an Ebola treatment?
Here's a closer look at whether the Tekmira vaccine is the answer everyone hopes it is...
Tekmira Pharma (Nasdaq: TKMR) stock surged more than 25% to $26.50 Wednesday after the CDC confirmed Tuesday the first Ebola diagnosis in the United States - and the first outside of Africa.
But just how close is Tekmira to getting approval for an Ebola treatment?
Here's a closer look at whether the Tekmira vaccine is the answer everyone hopes it is...
